Skip to main content
Erschienen in: Hepatology International 3/2010

01.09.2010 | Original Article

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection

verfasst von: Ching-Sheng Hsu, Chia-Chi Wang, Pin-Chao Wang, Hans Hsienhong Lin, Tai-Chung Tseng, Chien-Hwa Chen, Wei-Chih Su, Chun-Jen Liu, Chi-Ling Chen, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao

Erschienen in: Hepatology International | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Although chronic liver disease is associated with gastroesophageal reflux disease (GERD), the impact of chronic hepatitis B virus (HBV) infection on this association remains unclear. We thus aimed to evaluate the relationship between chronic HBV infection and GERD.

Methods

In this prospective population-based study, 1,001 adult subjects who underwent an upper gastrointestinal endoscopic examination in a health check-up and completed a gastroesophageal reflux questionnaire were consecutively enrolled. Endoscopic findings were classified according to the Los Angeles classification. Hepatitis B surface antigen was used as a marker of HBV infection. Univariate and multivariate approaches were used to evaluate the effects of chronic HBV infection on GERD.

Results

Chronic HBV infection was associated with heartburn sensation [odds ratio (OR) 1.27, 95% confidence interval 1.01–1.61, P = 0.037], and erosive esophagitis (adjusted OR 1.75, 1.03–2.97, P = 0.037). Although male gender is a risk factor of erosive esophagitis, further analyses stratified by gender and aspartate aminotransferase to platelet ratio index (APRI) showed that chronic HBV infection was associated with erosive esophagitis in female subjects (adjusted OR 2.70, 1.14–6.39, P = 0.024) and those with APRI of more than 0.3 (adjusted OR 3.94, 1.73–8.96, P = 0.001). Moreover, higher serum aspartate aminotransferase (AST) and triglyceride (TG) levels were risk factors of erosive esophagitis in patients with chronic HBV infection.

Conclusions

Our findings indicate a close association between chronic HBV infection and GERD, especially in female subjects and those with higher APRI levels. Moreover, HBV carriers with higher AST or TG levels have higher incidence of erosive esophagitis. The interactions between chronic HBV infection and GERD need further studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395–403CrossRefPubMed Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395–403CrossRefPubMed
2.
Zurück zum Zitat Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009;58:174–181CrossRefPubMed Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009;58:174–181CrossRefPubMed
3.
Zurück zum Zitat Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007;132:87–95CrossRefPubMed Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007;132:87–95CrossRefPubMed
4.
Zurück zum Zitat Katz PO, Castell DO. Approach to the patient with unexplained chest pain. Am J Gastroenterol 2000;95:S4–S8CrossRefPubMed Katz PO, Castell DO. Approach to the patient with unexplained chest pain. Am J Gastroenterol 2000;95:S4–S8CrossRefPubMed
5.
Zurück zum Zitat Suzuki K, Koizumi K, Takada H, Nishiki R, Ichimura H, Oka S, et al. Effect of symptomatic gastroesophageal reflux disease on quality of life of patients with chronic liver disease. Hepatol Res 2008;38:335–339CrossRefPubMed Suzuki K, Koizumi K, Takada H, Nishiki R, Ichimura H, Oka S, et al. Effect of symptomatic gastroesophageal reflux disease on quality of life of patients with chronic liver disease. Hepatol Res 2008;38:335–339CrossRefPubMed
6.
Zurück zum Zitat Ahmed AM, al Karawi MA, Shariq S, Mohamed AE. Frequency of gastroesophageal reflux in patients with liver cirrhosis. Hepatogastroenterology 1993;40:478–480PubMed Ahmed AM, al Karawi MA, Shariq S, Mohamed AE. Frequency of gastroesophageal reflux in patients with liver cirrhosis. Hepatogastroenterology 1993;40:478–480PubMed
8.
Zurück zum Zitat He J, Neal B, Gu D, Suriyawongpaisal P, Xin X, Reynolds R, et al. International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis 2004;14:260–268PubMed He J, Neal B, Gu D, Suriyawongpaisal P, Xin X, Reynolds R, et al. International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis 2004;14:260–268PubMed
9.
Zurück zum Zitat Liu CH, Lin JW, Tsai FC, Yang PM, Lai MY, Chen JH, et al. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 2006;26:1087–1094CrossRefPubMed Liu CH, Lin JW, Tsai FC, Yang PM, Lai MY, Chen JH, et al. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 2006;26:1087–1094CrossRefPubMed
10.
Zurück zum Zitat Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52–57CrossRefPubMed Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52–57CrossRefPubMed
11.
Zurück zum Zitat Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92CrossRefPubMed Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92CrossRefPubMed
12.
Zurück zum Zitat Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 1997;202:1–16PubMed Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 1997;202:1–16PubMed
13.
Zurück zum Zitat Hongbo L, Xiaohui L, Hong K, Wei W, Yong Z. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation. Clin Biochem 2007;40:562–566CrossRefPubMed Hongbo L, Xiaohui L, Hong K, Wei W, Yong Z. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation. Clin Biochem 2007;40:562–566CrossRefPubMed
14.
Zurück zum Zitat Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008;40:267–274CrossRefPubMed Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008;40:267–274CrossRefPubMed
15.
Zurück zum Zitat Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B. Hepatology 2005;41:1434–1435CrossRefPubMed Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B. Hepatology 2005;41:1434–1435CrossRefPubMed
16.
Zurück zum Zitat Labenz J, Jaspersen D, Kulig M, Leodolter A, Lind T, Meyer-Sabellek W, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652–1656CrossRefPubMed Labenz J, Jaspersen D, Kulig M, Leodolter A, Lind T, Meyer-Sabellek W, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652–1656CrossRefPubMed
17.
Zurück zum Zitat Dickman R, Mattek N, Holub J, Peters D, Fass R. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007;102:1173–1179CrossRefPubMed Dickman R, Mattek N, Holub J, Peters D, Fass R. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007;102:1173–1179CrossRefPubMed
18.
Zurück zum Zitat Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754–758CrossRefPubMed Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754–758CrossRefPubMed
19.
Zurück zum Zitat Ruszniewski P, Soufflet C, Barthelemy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther 2008;28:1134–1139CrossRefPubMed Ruszniewski P, Soufflet C, Barthelemy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther 2008;28:1134–1139CrossRefPubMed
20.
Zurück zum Zitat Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644–1651CrossRefPubMed Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644–1651CrossRefPubMed
21.
Zurück zum Zitat Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Yang WJ, et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci USA 2007;104:2571–2578CrossRefPubMed Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Yang WJ, et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci USA 2007;104:2571–2578CrossRefPubMed
22.
Zurück zum Zitat Nordenstedt H, Zheng Z, Cameron AJ, Ye W, Pedersen NL, Lagergren J. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology 2008;134:921–928CrossRefPubMed Nordenstedt H, Zheng Z, Cameron AJ, Ye W, Pedersen NL, Lagergren J. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology 2008;134:921–928CrossRefPubMed
23.
Zurück zum Zitat Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009;58:111–117CrossRefPubMed Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009;58:111–117CrossRefPubMed
24.
Zurück zum Zitat Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol 2007;47:191–202CrossRefPubMed Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol 2007;47:191–202CrossRefPubMed
25.
Zurück zum Zitat Iwasaki E, Suzuki H, Sugino Y, Iida T, Nishizawa T, Masaoka T, et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol 2008;23(Suppl 2):S216–S221CrossRefPubMed Iwasaki E, Suzuki H, Sugino Y, Iida T, Nishizawa T, Masaoka T, et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol 2008;23(Suppl 2):S216–S221CrossRefPubMed
Metadaten
Titel
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
verfasst von
Ching-Sheng Hsu
Chia-Chi Wang
Pin-Chao Wang
Hans Hsienhong Lin
Tai-Chung Tseng
Chien-Hwa Chen
Wei-Chih Su
Chun-Jen Liu
Chi-Ling Chen
Ming-Yang Lai
Pei-Jer Chen
Ding-Shinn Chen
Jia-Horng Kao
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Hepatology International / Ausgabe 3/2010
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-010-9184-4

Weitere Artikel der Ausgabe 3/2010

Hepatology International 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.